Status
Terminated
Drug Enforcement D-844-2013
Defective container: products are packaged in pouches which may not have been fully sealed
Classification
Class II
Report Date
August 14, 2013
Termination Date
November 4, 2014
Product Information
- Product description
- Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702 Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches. The foreign packaging do not have NDC numbers
- Product quantity
- 10,624,000 pouches
- Reason for recall
- Defective container: products are packaged in pouches which may not have been fully sealed
- Recall initiation reason
- —
- Initial firm notification
- Letter
- Distribution pattern
- Nationwide, Puerto Rico, Brazil and Panama
Location & Firm
- Recalling firm
- Novartis Consumer Health
- Address
-
10401 Hwy 6, N/A
United States - Voluntary / Mandated
- Voluntary: Firm initiated
- Status date
- —
Codes & Dates
- Recall number
- D-844-2013
- Event ID
- 65422
- Recall initiation date
- June 6, 2013
- Center classification date
- August 6, 2013
- Code info
- Lot # a) 10116809, Exp 5/13 Foreign: Lot #s b) 10115644 Exp 5/13; 10118226 Exp 5/13; 10118227 Exp 6/13; 10118228 Exp 6/13; 10121956 Exp 8/13 and 10121957 Exp 8/13
- More code info
- —